Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience's Partner Hibercell Ends Cooperation On Petra01 Program

Nov 21 (Reuters) - Sprint Bioscience AB (publ)
 SPRINT.ST :
    * SAID ON SATURDAY COMPANY'S PARTNER HIBERCELL WISHES TO END
EXCLUSIVE COOPERATION AGREEMENT REGARDING PETRA01 PROGRAM THAT
THE COMPANIES HAVE HAD SINCE MARCH 2021
    * SPRINT BIOSCIENCE WILL BEGIN PROCESS OF FINDING A NEW
LICENSE
PARTNER AS SOON AS POSSIBLE
    * SPRINT BIOSCIENCE AND HIBERCELL ARE NOW ENTERING INTO
FORMAL
NEGOTIATIONS REGARDING THE TERMS FOR THE RETURN OF THE PROGRAM
AND ALL RELATED DOCUMENTATION AND OWNERSHIP RIGHTS

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFN7cjxxJ
 Further company coverage:  SPRINT.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Sprint Bioscience AB

See all news